Orléans, France

Herve Vandepoel

This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herve Vandepoel. Retrieved from https://idiyas.com/inventor/herve-vandepoel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Herve Vandepoel: Innovator in Melatonergic Agents

Introduction

Herve Vandepoel is a notable inventor based in Orléans, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with the melatoninergic system. His work is essential for advancing treatments for various disorders related to melatonin.

Latest Patents

Herve Vandepoel holds a patent for "Pyridine compounds as melatonergic agents." This invention relates to a compound selected from a specific formula, which includes various defined components. The medicinal product containing these compounds is useful for treating disorders of the melatoninergic system. He has 1 patent to his name.

Career Highlights

Vandepoel is associated with Adir Et Compagnie, where he applies his expertise in medicinal chemistry. His work focuses on innovative solutions that address critical health issues related to melatonin.

Collaborations

Some of his notable coworkers include Pierre Renard and Daniel Mazeas. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Herve Vandepoel's contributions to the field of medicinal chemistry, particularly through his patent on melatonergic agents, highlight his role as an innovator. His work continues to pave the way for new treatments that can improve health outcomes related to melatonin disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…